Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:33:41-47.
doi: 10.1007/8904_2016_579. Epub 2016 Jul 22.

Brain White Matter Integrity Mediates the Relationship Between Phenylalanine Control and Executive Abilities in Children with Phenylketonuria

Affiliations

Brain White Matter Integrity Mediates the Relationship Between Phenylalanine Control and Executive Abilities in Children with Phenylketonuria

Anna Hood et al. JIMD Rep. 2017.

Abstract

We tested the hypothesis that brain white matter integrity mediates the relationship between phenylalanine (Phe) control and executive abilities in children with phenylketonuria (PKU; N = 36). To do so, we examined mean diffusivity (MD) from diffusion tensor imaging (DTI) in two white matter brain regions (posterior parietal-occipital, PPO; centrum semiovale, CSO) and lifetime phenylalanine (Phe) exposure; the executive abilities examined included verbal strategic processing, nonverbal strategic processing, and working memory. Mediation modeling showed that MD in the PPO and CSO mediated the relationship between Phe exposure and nonverbal strategic processing, MD in the CSO mediated the relationship between Phe exposure and verbal strategic processing, and MD in the PPO mediated the relationship between Phe exposure and working memory. These exploratory findings demonstrate the importance of using sophisticated modeling procedures to understand the interplay among metabolic control, neural factors, and functional outcomes in individuals with PKU.

Keywords: Brain; Executive abilities; Mediation; Neuroimaging; Phenylketonuria; White matter.

PubMed Disclaimer

Conflict of interest statement

Anna Hood, Jerrel Rutlin, and Joshua Shimony declare that they have no conflict of interest. Desiree White and Dorothy Grange have received research grants from BioMarin Pharmaceutical Inc. and have served as consultants for BioMarin Pharmaceutical Inc.

Figures

Fig. 1
Fig. 1
ROI placement
Fig. 2
Fig. 2
PPO and CSO as mediators of the relationships between mean Phe exposure and executive abilities

Similar articles

Cited by

References

    1. Anderson PJ, Wood SJ, Francis DE, Coleman L, Anderson V, Boneh A. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels? Dev Neuropsychol. 2007;32(2):645–668. doi: 10.1080/87565640701375963. - DOI - PubMed
    1. Antenor-Dorsey JAV, Hershey T, Rutlin J, Shimony JS, McKinstry RC, Grange DK, White DA. White matter integrity and executive abilities in individuals with phenylketonuria. Mol Genet Metab. 2013;109(2):125–131. doi: 10.1016/j.ymgme.2013.03.020. - DOI - PMC - PubMed
    1. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008;7(12):1139–1151. doi: 10.1016/S1474-4422(08)70259-X. - DOI - PubMed
    1. Christ SE, Steiner RD, Grange DK, Abrams RA, White DA. Inhibitory control in children with phenylketonuria. Dev Neuropsychol. 2006;30(3):845–864. doi: 10.1207/s15326942dn3003_5. - DOI - PubMed
    1. Christ SE, Huijbregts SCJ, de Sonneville LMJ, White DA. Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol Genet Metab. 2010;99:S22–S32. doi: 10.1016/j.ymgme.2009.10.007. - DOI - PubMed

LinkOut - more resources